Lonza | LONN - Cost Of Sales



Lonza reported CHF2.47B in Cost of Sales for its fiscal semester ending in December of 2024.


Cost Of Sales Change Date
Akzo Nobel EUR 1.59B 23M Jun/2025
Alcon AG USD 1.21B 118M Jun/2025
Almirall EUR 195.09M 100.89M Jun/2025
AstraZeneca USD 2.47B 232M Jun/2025
BASF EUR 11.59B 957M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Beiersdorf EUR 2.11B 130M Jun/2025
Covestro EUR 2.83B 185M Jun/2025
Demant DKK 2.71B 46M Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Geberit CHF 229.1M 16.1M Mar/2025
Genmab DKK 57M 15M Jun/2025
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GN Store Nord DKK 1.93B 136M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Johnson Matthey GBP 5.55B 329M Mar/2025
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Philips EUR 2.33B 79M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
Sika AG CHF 1.31B 1.38B Jun/2024
Smith & Nephew USD 870M 41M Jun/2025
Solvay EUR 960M 31M Jun/2025
UCB EUR 901M 50M Dec/2024